Press Releases from Roots Analysis (288 total)
The soft tissue sarcoma market is projected to be worth over USD 420 million in …
Recent advances in molecular biology have enabled researchers to develop a better understanding of the rare soft tissue sarcomas; as a result, a number of…
The squamous non-small cell lung cancer market is projected to grow at a CAGR of …
Over time, important advances in diagnosis and the development of versatile treatment options have translated into tangible improvements in the overall survival of lung cancer…
Porphyria Targeting Therapies Market, 2021-2030
Roots Analysis has announced the addition of “Porphyria Targeting Therapies Market, 2021-2030” report to its list of offerings.
Porphyria is a rare disorder that is…
Display Library Technologies and Affiliated Services Market by Roots Analysis
Given the various limitations of the conventional drug discovery methods, the innovator companies are increasingly adopting the advanced technologies, such as display-library technologies for rapid…
Elastomeric Closure Components Market by Roots Analysis
To order this detailed 400+ page report, please visit this - https://www.rootsanalysis.com/reports/view_document/elastomeric-closures-market-focus-on-parenteral-containers-2019-2030/255.html
Key Inclusions
A detailed assessment of the current market landscape of companies manufacturing elastomeric container…
The global collaborative robots (cobots) market is projected to be worth USD 18 …
Roots Analysis is pleased to announce the publication of its recent study, titled, “Global Collaborative Robots (Cobots) Market, 2020-2030.”
The report features an extensive study of…
Global Psychedelic therapeutics market is estimated to be worth over USD 6.5 bil …
A growing body of evidence suggests that using psychedelics, such as psilocybin and LSD, in combination with psychotherapy, can treat the symptoms of several mental…
The microbial contract biomanufacturing market is estimated to be worth USD 9.3 …
Benefits offered by microbial biomanufacturing, such as low production costs and faster development timelines, have led many innovators to adopt these platforms for next generation…
The porphyria therapies market is projected to grow at an annualized rate of 10. …
Several novel and innovative therapeutic approaches, both small molecule and biologics, are being currently investigated at various phases of development in order to avoid the…
Elastomeric Closure Components Market by Roots Analysis
To order this detailed 400+ page report, please visit this - https://www.rootsanalysis.com/reports/view_document/elastomeric-closures-market-focus-on-parenteral-containers-2019-2030/255.html
Key Inclusions
A detailed assessment of the current market landscape of companies manufacturing elastomeric container…
The viral and non-viral vector manufacturing market is projected to grow at an a …
The rapidly growing pipeline of genetically modified therapies reflects the surge in demand for high quality vectors, presenting lucrative opportunities for companies with the capabilities…
Targeted Protein Degradation Market, 2021-2030
Targeted protein degradation has emerged as a revolutionary pharmacological concept that presents both viable and versatile drug development opportunities and is anticipated to introduce a…
Real World Evidence Market, (2nd Edition) - Roots Analysis
In modern healthcare, the applications of real world data-based insights are vast, ranging from drug discovery to supporting regulatory decision-making; in fact, the US FDA…
RAS Targeting Therapies Market, 2021-2031 by Roots
Roots Analysis has announced the addition of “RAS Targeting Therapies Market, 2021-2031” report to its list of offerings.
To order this 140+ page report, which features…
The porphyria therapies market is projected to grow at an annualized rate of 10. …
Several novel and innovative therapeutic approaches, both small molecule and biologics, are being currently investigated at various phases of development in order to avoid the…
The outsourced cell therapy consumables market is likely to grow at a significan …
In order to keep pace with ongoing advances related to materials and regulatory scenarios, and to facilitate the cell therapy manufacturing process, cell therapy consumable…
The squamous non-small cell lung cancer market is projected to grow at a CAGR of …
Over time, important advances in diagnosis and the development of versatile treatment options have translated into tangible improvements in the overall survival of lung cancer…
The teleradiology services market is projected to grow at a CAGR of 16.8% till 2 …
Roots Analysis has announced the addition of “Teleradiology Services Market, 2021-2030” market report to its list of offerings.
The report features an extensive study of the…
The Alzheimer’s disease market is anticipated to grow at an annualized rate of …
The recent approval of Aduhelm™, an amyloid beta-directed antibody has led to players seeking approval for similar therapies; various interventions are being evaluated for the…
The glycosylation analysis services market is projected to reach nearly USD 2.5 …
The rapidly growing pipeline of recombinant glycoprotein therapeutics, especially the glycoengineered variants of COVID-19 drugs, has presented lucrative opportunities for contract service providers with expertise…
The progressive supranuclear palsy (PSP) therapies market, is projected to grow …
The exact cause of this rare disorder, which affects 5-17 in 100,000 people, is unknown; however, a complex interplay between different risk factors, including age,…
The light activated therapies market is anticipated to grow at an annualized rat …
Light activated therapies are considered to be a transformative approach owing to their capability to eradicate diseased cells from the body with minimal side effects;…
Pharmaceutical Contract Research Services Market, 2021-2030 by Roots Analysis
Customized services, reduced cost and access to advanced technologies offered by contract research service providers, have prompted a number of pharmaceutical companies to outsource their…
Novel Drug Reconstitution Systems Market, 2021-2030
Roots Analysis has announced the addition of “Novel Drug Reconstitution Systems Market, 2021-2030” report to its list of offerings.
To order this 320+ page report,…
The “RAS Targeting Therapies Market, 2021-2031” report features an extensive …
To order this 140+ page report, which features 95+ figures, please visit https://www.rootsanalysis.com/reports/ras-targeting-therapies-market.html
Key Inclusions
A detailed overview of the current market landscape of RAS targeting therapies,…
The novel ocular drug delivery devices market is projected to grow at a CAGR of …
The delivery of drugs in ocular regions is known to be considerably more challenging; several pharmaceutical companies are actively undertaking initiatives to identify novel approaches…
The top selling biologics market is projected to be worth USD 156 billion by 203 …
Owing to the numerous benefits offered by biologics, this drug class has become an integral part of the overall pharmaceutical industry, having captured a significant…
The bioprocess controllers and automation systems market is projected to be grow …
Owing to their advanced features and cost saving potential, bioprocess controllers and automation systems have been adopted widely by stakeholders in order to optimize and…
The TIL-based therapies market is projected to be worth over USD 4.3 billion, by …
The TIL-based therapies market is projected to be worth over USD 4.3 billion, by 2030, claims Roots Analysis
LONDON, ENGLAND, UNITED KINGDOM, October 5, 2021 /EINPresswire.com/…
The on-body drug delivery-related intellectual landscape report identifies and a …
Several innovative drug delivery technologies have gathered notable momentum (in terms of adoption and sales) soon after entering the market; most of these are designed…
The biospecimen contract research market is projected to grow at a noteworthy pa …
In the ongoing COVID-19 pandemic, a surge in the number of research studies has been observed, presenting lucrative opportunities for biospecimen service providers having the…
With over 20 approved products and several more in the pipeline, the HUMIRA® bi …
Unlike other biosimilar markets, competition among follow-on products of HUMIRA® is very high and several eager companies are attempting to carve out a share of…
The non-hormonal therapies market is projected to be worth USD 10.9 billion in 2 …
Driven by the potential to confer safe and sustained therapeutic effects for clinical conditions unique to women, the non-hormonal therapies pipeline is growing, featuring candidates…
The glycosylation analysis services market is projected to reach nearly USD 2.5 …
The rapidly growing pipeline of recombinant glycoprotein therapeutics, especially the glycoengineered variants of COVID-19 drugs, has presented lucrative opportunities for contract service providers with expertise…
The continuous and semi-continuous bioprocessing market is projected to grow at …
The surge in demand for COVID-19 vaccines has presented lucrative opportunities for both innovators and contract service providers having continuous and semi-continuous manufacturing capabilities for…
The glycosylation analysis services market is projected to reach nearly USD 2.5 …
The rapidly growing pipeline of recombinant glycoprotein therapeutics, especially the glycoengineered variants of COVID-19 drugs, has presented lucrative opportunities for contract service providers with expertise…
The CRISPR based therapeutics market is projected to be worth around USD 2.2 bil …
Considering its potential to intricately alter genetic DNA, the CRISPR technology is being widely used to develop viable therapeutics for the treatment of rare and…
The global cell therapy packaging services market is projected to be worth USD 1 …
With the growing pipeline of cell therapy products as potential treatments options for a myriad of diseases, drug developers are likely to collaborate with players…
The TIL-based therapies market is projected to be worth over USD 4.3 billion, by …
Driven by the potential to confer sustained therapeutic effects and thereby, facilitate prolonged periods of remission, TIL-based therapies have received significant financial support, and promising…
The opportunity within the display library technologies and services market is p …
Given the various limitations of the conventional drug discovery methods, the innovator companies are increasingly adopting the advanced technologies, such as display-library technologies for rapid…
The viral and non-viral vector manufacturing market is projected to grow at an a …
The rapidly growing pipeline of genetically modified therapies reflects the surge in demand for high quality vectors, presenting lucrative opportunities for companies with the capabilities…
The vascular disrupting agents market is projected to be worth USD 2 billion by …
Vascular disrupting agents (VDAs) are the novel oncology drugs being developed to more specifically combat complex, life threatening cancer indications
London
Roots Analysis has announced the addition…
The targeted protein degradation enabling technologies market, featuring a healt …
Targeted protein degradation has emerged as a revolutionary pharmacological concept that presents both viable and versatile drug development opportunities and is anticipated to introduce a…
The immunocytokines market is estimated to be worth around USD 5.4 billion by 20 …
Advances in molecular biology and tumor immunology have enabled the development of therapeutic fusion proteins, having the ability to activate immunologically cold microenvironments without the…
The antibody purification services market is projected to be worth USD 2.02 bill …
Amidst the COVID-19 pandemic, there has been an evident surge in demand for standard quality antibodies for research, diagnosis and therapeutic purposes, which has presented…
The cloud-based solutions for drug discovery, development and manufacturing mark …
The growing complexities surrounding modern therapy development initiatives have caused biopharmaceutical companies to adopt available cloud-based solutions, to not only expedite associated timelines, but also…
The cell therapy manufacturing market is projected to reach USD 14.5 billion by …
Given the consistent increase in number of cell therapies being developed and launched, this upcoming therapeutic segment is on its way to becoming one of…
The biopharmaceutical CROs market is projected to be worth USD 67 billion by 203 …
Over past few years, pharmaceutical companies have outsourced various aspects of their R&D and clinical research processes to specialty contract research service providers, in order…
The gene therapy market is estimated to be worth USD 11.6 billion in 2030, predi …
With multiple approved products, the field of gene therapies has gained substantial momentum over the last couple of decades; innovator companies are gradually progressing their…
Growing at an annualized rate of 10%, the fragment-based drug discovery market i …
Traditional drug discovery is associated with exorbitant investments, prolonged lead evolution timelines and high attrition rates; the fragment-based approach is a versatile technique, enabling researchers…
